致力于 改善人类身心健康的事业

Committed to the cause of improving THE physical and mental health OF HUMANS

ABOUT FONCOO

1999 year

Company Founding

5000

+

Covering Hospitals Nationwide

5

+

Million

Serving Mental Disorders

Shenzhen Foncoo Pharmaceutical Co., Ltd.

Shenzhen Foncoo Pharmaceutical Co., Ltd. specializes in providing pharmaceutical products that treat Central Nervous System disorders. Founded in 1999, Shenzhen Foncoo is a professional supplier of pharmaceutical products for mental illness.

 

According to data from the WHO, around one billion people worldwide suffer from mental disorders. China alone has about 240 million mental patients. While 16.6% of them live with their diseases the entire life, only 13.55% are treated.

 

Shenzhen Foncoo is committed to the cause of improving the physical and mental health of humans and strives to provide Chinese patients with premium-quality CNS medicine. The goal of Shenzhen Foncoo is to become the most respected mental healthcare leader in 10 years. 

More +

Products

news center

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.

2022-06-21

2021-Foncoo Public Welfare

On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.

2022-06-21

Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Official announcement! Seriously, don't be distracted!

2022-06-21

Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.

2022-06-21

"Bupropion Hydrochloride Sustained-Release Tablets (II)" exclusively sold by Foncoo Pharmaceuticals was approved in China

Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.

2022-06-21

Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".

2022-06-21

Foncoo Pharmaceutical participated in the 2021 China Affective Disorder Conference

From October 14th to 16th, 2021, Foncoo Pharmaceutical participated in the "2021 China Emotional Conference" and organized a special meeting on "New Progress in Drug Treatment of Bipolar Disorder".

2022-06-21

Welfare||Use your hands and brains, full of fun in the Mid-Autumn Festival

I hope you can bring your own light, as well as the moon in the Mid-Autumn Festival~ (there is a little surprise at the end of the article)

2022-06-21

Culture | Feather with you, share happiness

We can not only have a busy work life, but also have a hearty sports team building.

2022-06-21

cooperation PARTNERs

图片名称
图片名称
图片名称
图片名称
图片名称
图片名称
图片名称
图片名称
图片名称
图片名称